The effect of hypoxia on chondrogenesis of equine synovial membrane-derived and bone marrow-derived mesenchymal stem cells.
Authors: Gale Alexis L, Mammone Renata M, Dodson Michael E, Linardi Renata L, Ortved Kyla F
Journal: BMC veterinary research
Summary
Mesenchymal stem cells from synovial membrane and bone marrow represent promising candidates for treating equine joint cartilage damage, yet their behaviour under different culture conditions requires clarification before clinical application. Researchers cultured both cell types under normoxic and hypoxic conditions, characterising them through stemness markers (CD29, CD44, CD90, CD105, MHCI) and confirming their identity by absence of haematopoietic markers before assessing their capacity to differentiate into chondrocytes. Whilst most chondrogenic differentiation variables were comparable between cell sources and oxygen conditions, hypoxic synovial membrane-derived cells demonstrated significantly lower expression of COL10A1—a key marker of pathological chondrocyte hypertrophy—compared to their bone marrow-derived counterparts under equivalent conditions. This finding suggests that culturing synovial membrane stem cells in hypoxic environments may reduce the risk of terminal chondrocyte differentiation and associated cartilage degeneration, potentially improving therapeutic outcomes in joint lesions. Practitioners considering stem cell therapies should recognise that culture conditions materially influence cell behaviour; hypoxia appears advantageous specifically for synovial membrane-derived cells, warranting consideration during cell preparation protocols prior to intra-articular administration.
Read the full abstract on PubMed
Practical Takeaways
- •Synovial membrane-derived stem cells may be a superior cell source for cartilage regeneration therapies due to reduced hypertrophic differentiation under physiologic oxygen conditions
- •The hypoxic microenvironment of joint lesions may naturally favor synovial-derived cells over bone marrow-derived alternatives for maintaining stable cartilage phenotype
- •Consider source tissue carefully when selecting stem cells for intra-articular injection—synovial origin shows mechanistic advantage for chondral repair
Key Findings
- •Both synovial membrane-derived and bone marrow-derived mesenchymal stem cells expressed consistent stemness markers (CD29, CD44, CD90, CD105, MHCI)
- •COL10A1 expression indicating chondrocyte hypertrophy was significantly lowest in hypoxic synovial membrane-derived MSCs compared to hypoxic bone marrow-derived MSCs
- •Most chondrogenic differentiation markers showed no significant differences between cell types or culture conditions
- •Hypoxic conditions may preferentially inhibit hypertrophic differentiation in synovial membrane-derived mesenchymal stem cells